Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24761509 | 0.89 | PAOX (0.36) | FOLH1 | |
| SCHEMBL3078846 | 0.80 | TSHR (0.45) | FOLH1TSHRLMNA | |
| SCHEMBL232206 | 0.78 | KDM4E (0.36) | LMNA | |
| SCHEMBL154713 | 0.76 | SOAT1 (0.39) | LMNA | |
| Hydrochloric Acid SCHEMBL561987 | 0.76 | KDM4E (0.35) | LMNA | |
| Hydrochloric Acid SCHEMBL691540 | 0.76 | KDM4E (0.35) | LMNA | |
| SCHEMBL181082 | 0.76 | TSHR (0.36) | TSHRLMNA | |
| SCHEMBL5067235 | 0.75 | TSHR (0.48) | FOLH1TSHRLMNA | |
| SCHEMBL3293803 | 0.75 | LMNA (0.38) | LMNA | |
| SCHEMBL22987326 | 0.75 | CNR1 (0.33) | FOLH1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3545963-A1 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | Synovis Orthopedic and Woundcare, Inc. (US) | 2019-10-02 | — | — | EP | disclosed |
| EP-2001521-B1 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | SYNOVIS ORTHOPEDIC AND WOUNDCARE INC (US) | 2019-07-31 | — | — | EP | disclosed |
| EP-3348280-A1 | CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS | Hangzhou Dac Biotech Co., Ltd (CN) | 2018-07-18 | — | — | EP | disclosed |
| US-9694037-B2 | Stabilized, sterilized collagen scaffolds with active adjuncts attached | SYNOVIS ORTHOPEDIC AND WOUNDCARE, INC. (US) | 2017-07-04 | — | — | US | disclosed |
| US-9272004-B2 | Stabilized, sterilized collagen scaffolds with active adjuncts attached | SYNOVIS ORTHOPEDIC AND WOUNDCARE, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| US-20100266559-A1 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | SYNOVIS ORTHOPEDIC AND WOUNDCARE, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-20090196898-A1 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | SYNOVIS LIFE TECHNOLOGIES, INC. | 2009-08-06 | — | — | US | disclosed |
| EP-2001521-A2 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | Pegasus Biologics, Inc. (US) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007109180-A2 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | PEGASUS BIOLOGICS, INC. (US) | 2007-09-27 | — | — | WO | disclosed |
| US-20070218038-A1 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | PEGASUS BIOLOGICS, INC. (US) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070218038-A1 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | COL14A1, COL1A1, COL2A1 | FOLH1 697/4885TSHR 3922/4885LMNA 2034/4885 |
| US-20100266559-A1 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | COL14A1, COL1A1, COL2A1 | FOLH1 697/4885TSHR 3922/4885LMNA 2034/4885 |
| US-20090196898-A1 | STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED | COL14A1, COL1A1, COL2A1 | FOLH1 697/4885TSHR 3922/4885LMNA 2034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.